6,000
Views
30
CrossRef citations to date
0
Altmetric
Review

Impacts of cannabinoid epigenetics on human development: reflections on Murphy et. al. ‘cannabinoid exposure and altered DNA methylation in rat and human sperm’ epigenetics 2018; 13: 1208-1221.

ORCID Icon &
Pages 1041-1056 | Received 04 May 2019, Accepted 13 Jun 2019, Published online: 11 Jul 2019

References

  • Krishna Kumar K, Shalev-Benami M, Robertson MJ, et al. Structure of a signaling cannabinoid receptor 1-G protein complex. Cell. 2019 Jan 24;176(3):448–458 e12.
  • Li X, Hua T, Vemuri K, et al. Crystal Structure of the Human Cannabinoid Receptor CB2. Cell. 2019 Jan 24;176(3):459–467 e13.
  • Luo X, Reiter MA, d’Espaux L, et al. Complete biosynthesis of cannabinoids and their unnatural analogues in yeast. Nature. 2019 Mar;567(7746):123–126.
  • Nestler EJ, Luscher C. The Molecular Basis of Drug Addiction: linking Epigenetic to Synaptic and Circuit Mechanisms. Neuron. 2019 Apr 3;102(1):48–59.
  • Rinn JL, Kertesz M, Wang JK, et al. Functional demarcation of active and silent chromatin domains in human HOX loci by noncoding RNAs. Cell. 2007 Jun 29;129(7):1311–1323.
  • Kotake Y, Nakagawa T, Kitagawa K, et al. Long non-coding RNA ANRIL is required for the PRC2 recruitment to and silencing of p15(INK4B) tumor suppressor gene. Oncogene. 2011 Apr 21;30(16):1956–1962.
  • Szutorisz H, Hurd YL. High times for cannabis: epigenetic imprint and its legacy on brain and behavior. Neurosci Biobehav Rev. 2018 Feb;85:93–101.
  • Ohno M, Ando T, Priest DG, et al. Sub-nucleosomal Genome Structure Reveals Distinct Nucleosome Folding Motifs. Cell. 2019 Jan 24;176(3):520–534 e25.
  • Mateo LJ, Murphy SE, Hafner A, et al. Visualizing DNA folding and RNA in embryos at single-cell resolution. Nature. 2019 Apr;568(7750):49–54.
  • Loven J, Hoke HA, Lin CY, et al. Selective inhibition of tumor oncogenes by disruption of super-enhancers. Cell. 2013 Apr 11;153(2):320–334.
  • Pefanis E, Wang J, Rothschild G, et al. RNA exosome-regulated long non-coding RNA transcription controls super-enhancer activity. Cell. 2015 May 7;161(4):774–789.
  • CJ O, Federation AJ, Schwartz LS, et al. Enhancer Architecture and Essential Core Regulatory Circuitry of Chronic Lymphocytic Leukemia. Cancer Cell. 2018 Dec 10;34(6):982–995 e7.
  • Fulciniti M, Lin CY, Samur MK, et al. Non-overlapping Control of Transcriptome by Promoter- and Super-Enhancer-Associated Dependencies in Multiple Myeloma. Cell Rep. 2018 Dec 26;25(13):3693–3705 e6.
  • Mack SC, Pajtler KW, Chavez L, et al. Therapeutic targeting of ependymoma as informed by oncogenic enhancer profiling. Nature. 2018 Jan 4;553(7686):101–105.
  • Szutorisz H, Egervari G, Sperry J, et al. Cross-generational THC exposure alters the developmental sensitivity of ventral and dorsal striatal gene expression in male and female offspring. Neurotoxicol Teratol. 2016;58:107–114.
  • Szutorisz H, Hurd YL. Epigenetic Effects of Cannabis Exposure. Biol Psychiatry. 2016 Apr 1;79(7):586–594.
  • Cecil CA, Walton E, Smith RG, et al. DNA methylation and substance-use risk: a prospective, genome-wide study spanning gestation to adolescence. Transl Psychiatry. 2016 Dec 6;6(12):e976.
  • DiNieri JA, Wang X, Szutorisz H, et al. Maternal cannabis use alters ventral striatal dopamine D2 gene regulation in the offspring. Biol Psychiatry. 2011 Oct 15;70(8):763–769.
  • Szutorisz H, DiNieri JA, Sweet E, et al. Parental THC exposure leads to compulsive heroin-seeking and altered striatal synaptic plasticity in the subsequent generation. Neuropsychopharmacology. 2014 May;39(6):1315–1323.
  • Watson CT, Szutorisz H, Garg P, et al. Neuropsychopharmacology. In: Genome-Wide DNA Methylation Profiling Reveals Epigenetic Changes in the Rat Nucleus Accumbens Associated With Cross-Generational Effects of Adolescent THC Exposure. Jun, 2015;40(13):2993–3005.
  • Yang X, Hegde VL, Rao R, et al. Histone modifications are associated with Delta9-tetrahydrocannabinol-mediated alterations in antigen-specific T cell responses. J Biol Chem. 2014 Jul 4;289(27):18707–18718.
  • Govorko D, Bekdash RA, Zhang C, et al. Male germline transmits fetal alcohol adverse effect on hypothalamic proopiomelanocortin gene across generations. Biol Psychiatry. 2012 Sep 1;72(5):378–388.
  • Fullston T, Ohlsson Teague EM, Palmer NO, et al. Paternal obesity initiates metabolic disturbances in two generations of mice with incomplete penetrance to the F2 generation and alters the transcriptional profile of testis and sperm microRNA content. Faseb J. 2013 Oct;27(10):4226–4243.
  • Waddington CH. The Epigenotype. Endeavour. 2019;1942:18–20.
  • Beerman I, Rossi DJ. Epigenetic Control of Stem Cell Potential during Homeostasis, Aging, and Disease. Cell Stem Cell. 2015 Jun 4;16(6):613–625.
  • Brumbaugh J, Hochedlinger K. Removing reprogramming roadblocks: mbd3 depletion allows deterministic iPSC generation. Cell Stem Cell. 2013 Oct 3;13(4):379–381.
  • Ding J, Huang X, Shao N, et al. Tex10 Coordinates Epigenetic Control of Super-Enhancer Activity in Pluripotency and Reprogramming. Cell Stem Cell. 2015 Jun 4;16(6):653–668.
  • Mansour AA, Gafni O, Weinberger L, et al. The H3K27 demethylase Utx regulates somatic and germ cell epigenetic reprogramming. Nature. 2012 Aug 16;488(7411):409–413.
  • Snoeck HW. Can Metabolic Mechanisms of Stem Cell Maintenance Explain Aging and the Immortal Germline?. Cell Stem Cell. 2015 Jun 4;16(6):582–584.
  • Huang SS, Clarke DC, Gosline SJ, et al. Linking proteomic and transcriptional data through the interactome and epigenome reveals a map of oncogene-induced signaling. PLoS Comput Biol. 2013;9(2):e1002887.
  • Ziech D, Franco R, Pappa A, et al. Reactive oxygen species (ROS)–induced genetic and epigenetic alterations in human carcinogenesis. Mutat Res. 2011 Jun 3;711(1–2):167–173.
  • Lao VV, Grady WM. Epigenetics and colorectal cancer. Nat Rev Gastroenterol Hepatol. 2011 Dec;8(12):686–700.
  • Dong X, Liao Z, Gritsch D, et al. Enhancers active in dopamine neurons are a primary link between genetic variation and neuropsychiatric disease. Nat Neurosci. 2018 Oct;21(10):1482–1492.
  • Guennewig B, Bitar M, Obiorah I, et al. THC exposure of human iPSC neurons impacts genes associated with neuropsychiatric disorders. Transl Psychiatry. 2018 Apr 25;8(1):89.
  • Kozlenkov A, Jaffe AE, Timashpolsky A, et al. DNA Methylation Profiling of Human Prefrontal Cortex Neurons in Heroin Users Shows Significant Difference between Genomic Contexts of Hyper- and Hypomethylation and a Younger Epigenetic Age. In: Genes (Basel), Vol. 8. 2017 May 30. p. 6.
  • Heyward FD, Gilliam D, Coleman MA, et al. Obesity Weighs down Memory through a Mechanism Involving the Neuroepigenetic Dysregulation of Sirt1. J Neurosci. 2016 Jan 27;36(4):1324–1335.
  • Villeneuve LM, Reddy MA, Lanting LL, et al. Epigenetic histone H3 lysine 9 methylation in metabolic memory and inflammatory phenotype of vascular smooth muscle cells in diabetes. Proc Natl Acad Sci U S A. 2008 Jul 1;105(26):9047–9052.
  • Halder R, Hennion M, Vidal RO, et al. DNA methylation changes in plasticity genes accompany the formation and maintenance of memory. Nat Neurosci. 2016 Jan;19(1):102–110.
  • Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet. 2003 Mar;33:Suppl:245–54.
  • Horvath S. DNA methylation age of human tissues and cell types. Genome Biol. 2013;14(10):R115.
  • Batie M, Frost J, Frost M, et al. Hypoxia induces rapid changes to histone methylation and reprograms chromatin. Science. 2019 Mar 15;363(6432):1222–1226.
  • Chakraborty AA, Laukka T, Myllykoski M, et al. Histone demethylase KDM6A directly senses oxygen to control chromatin and cell fate. Science. 2019 Mar 15;363(6432):1217–1222.
  • Vodnala SK, Eil R, Kishton RJ, et al. T cell stemness and dysfunction in tumors are triggered by a common mechanism. Science. 2019;363(6434):eaau0135.
  • Canto C, Menzies KJ, Auwerx J. NAD(+) Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus. Cell Metab. 2015 Jul 7;22(1):31–53.
  • Benard G, Massa F, Puente N, et al. Mitochondrial CB(1) receptors regulate neuronal energy metabolism. Nat Neurosci. 2012 Mar 4;15(4):558–564.
  • Hebert-Chatelain E, Desprez T, Serrat R, et al. A cannabinoid link between mitochondria and memory. Nature. 2016 Nov 24;539(7630):555–559.
  • Hebert-Chatelain E, Reguero L, Puente N, et al. Cannabinoid control of brain bioenergetics: exploring the subcellular localization of the CB1 receptor. Mol Metab. 2014 Jul;3(4):495–504.
  • Wolff V, Schlagowski AI, Rouyer O, et al. Tetrahydrocannabinol induces brain mitochondrial respiratory chain dysfunction and increases oxidative stress: a potential mechanism involved in cannabis-related stroke. Biomed Res Int. 2015;2015:323706.
  • Djeungoue-Petga MA, Linking Mitochondria H-CE. Synaptic Transmission: the CB1 Receptor. Bioessays. 2017 Dec;39(12). doi: 10.1002/bies.201700126. Epub 2017 Oct 23.
  • Ruggiero A, Aloni E, Korkotian E, et al. Loss of forebrain MTCH2 decreases mitochondria motility and calcium handling and impairs hippocampal-dependent cognitive functions. Sci Rep. 2017 Mar 9;7:44401.
  • Sarafian TA, Kouyoumjian S, Khoshaghideh F, et al. Delta 9-tetrahydrocannabinol disrupts mitochondrial function and cell energetics. Am J Physiol. 2003 Feb;284(2):L298–306.
  • Sarafian TA, Habib N, Oldham M, et al. Inhaled marijuana smoke disrupts mitochondrial energetics in pulmonary epithelial cells in vivo. Am J Physiol. 2006 Jun;290(6):L1202–9.
  • Rossato M, Ion Popa F, Ferigo M, et al. Human sperm express cannabinoid receptor Cb1, the activation of which inhibits motility, acrosome reaction, and mitochondrial function. J Clin Endocrinol Metab. 2005 Feb;90(2):984–991.
  • Cervantes M, Sassone-Corsi P. Modification of histone proteins by serotonin in the nucleus. Nature. 2019 Mar;567(7749):464–465.
  • Farrelly LA, Thompson RE, Zhao S, et al. Histone serotonylation is a permissive modification that enhances TFIID binding to H3K4me3. Nature. 2019 Mar;567(7749):535–539.
  • Bhattacharyya S, Pradhan K, Campbell N, et al. Altered hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways. Genome Res. 2017 Nov;27(11):1830–1842.
  • Stead LF, Verhaak RGW. Doomed from the TERT? A Two-Stage Model of Tumorigenesis in IDH-Wild-Type Glioblastoma. Cancer Cell. 2019 Apr 15;35(4):542–544.
  • Weintraub AS, Li CH, Zamudio AV, et al. YY1 Is a Structural Regulator of Enhancer-Promoter Loops. Cell. 2017 Dec 14;171(7):1573–1588 e28.
  • Zeid R, Lawlor MA, Poon E, et al. Enhancer invasion shapes MYCN-dependent transcriptional amplification in neuroblastoma. Nat Genet. 2018 Apr;50(4):515–523.
  • Kohnken R, Wen J, Mundy-Bosse B, et al. Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma. Blood. 2018 Feb 15;131(7):771–781.
  • Liu Y, Li Y, Liu S, et al. NK Cells Mediate Synergistic Antitumor Effects of Combined Inhibition of HDAC6 and BET in a SCLC Preclinical Model. Cancer Res. 2018 Jul 1;78(13):3709–3717.
  • Michel BC, D’Avino AR, Cassel SH, et al. A non-canonical SWI/SNF complex is a synthetic lethal target in cancers driven by BAF complex perturbation. Nat Cell Biol. 2018 Dec;20(12):1410–1420.
  • Su R, Dong L, Li C, et al. R-2HG Exhibits Anti-tumor Activity by Targeting FTO/m(6)A/MYC/CEBPA Signaling. Cell. 2018 Jan 11;172(1–2):90–105 e23.
  • Xu L, Chen Y, Mayakonda A, et al. Targetable BET proteins- and E2F1-dependent transcriptional program maintains the malignancy of glioblastoma. Proc Natl Acad Sci U S A. 2018 May 29;115(22):E5086–E5095.
  • Bandopadhayay P, Piccioni F, O’Rourke R, et al. Neuronal differentiation and cell-cycle programs mediate response to BET-bromodomain inhibition in MYC-driven medulloblastoma. Nat Commun. 2019 Jun 3;10(1):2400.
  • Hemming ML, Lawlor MA, Andersen JL, et al. Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and Are Targetable by BET Bromodomain Inhibition. Cancer Res. 2019 Mar 1;79(5):994–1009.
  • MillerAL, FehlingSC, GarciaPL, et al. EBioMedicine. In: The BET inhibitor JQ1 attenuates double-strand break repair and sensitizes models ofpancreatic ductal adenocarcinoma to PARP inhibitors. May,2019;44:419–430.Epub 2019 May22doi:10.1016/j.ebiom.2019.05.035.
  • Sdelci S, Rendeiro AF, Rathert P, et al. MTHFD1 interaction with BRD4 links folate metabolism to transcriptional regulation. Nat Genet. 2019 Jun;51(6):990–998.
  • FierceBiotech. Jay Bradner - Novartis: FiercePharma; 2018 [cited 2019 Jun 6]. Available from: https://www.fiercebiotech.com/special-report/jay-bradner-novartis
  • Novartis. James (Jay) Bradner, President of Novartis Institutes for Biomedical Research (NIBR) Cambridge, Massachusetts, USA: Novartis; 2019 [cited 2019 Jun 9]. Available from: https://www.fiercebiotech.com/special-report/jay-bradner-novartis
  • Murphy SK, Itchon-Ramos N, Visco Z, et al. Epigenetics. In: Cannabinoid exposure and altered DNA methylation in rat and human sperm. Epigenetics. 2018;13(12):1208–1221..
  • Liu S, Kwon M, Mannino M, et al. Nuclear envelope assembly defects link mitotic errors to chromothripsis. Nature. 2018 Sep;561(7724):551–555.
  • Reece AS. Chronic toxicology of cannabis. Clin Toxicol (Phila). 2009 Jul;47(6):517–524.
  • Callaghan RC, Allebeck P, Akre O, et al. Cannabis Use and Incidence of Testicular Cancer: A 42-Year Follow-up of Swedish Men between 1970 and 2011. Cancer Epidemiol Biomarkers Prev. 2017 Nov;26(11):1644–1652.
  • Daling JR, Doody DR, Sun X, et al. Association of marijuana use and the incidence of testicular germ cell tumors. Cancer. 2009 Mar 15;115(6):1215–1223.
  • Lacson JC, Carroll JD, Tuazon E, et al. Population-based case-control study of recreational drug use and testis cancer risk confirms an association between marijuana use and nonseminoma risk. Cancer. 2012 Nov 1;118(21):5374–5383.
  • Trabert B, Sigurdson AJ, Sweeney AM, et al. Marijuana use and testicular germ cell tumors. Cancer. 2011 Feb 15;117(4):848–853.
  • Gurney J, Shaw C, Stanley J, et al. Cannabis exposure and risk of testicular cancer: a systematic review and meta-analysis. BMC Cancer. 2015 11;Nov(15):897.
  • Sweet-Cordero EA, Biegel JA. The genomic landscape of pediatric cancers: implications for diagnosis and treatment. Science. 2019 Mar 15;363(6432):1170–1175.
  • Lam CG, Howard SC, Bouffet E, et al. Science and health for all children with cancer. Science. 2019 Mar 15;363(6432):1182–1186.
  • David AL, Holloway A, Thomasson L, et al. A case-control study of maternal periconceptual and pregnancy recreational drug use and fetal malformation using hair analysis. PLoS One. 2014;9(10):e111038.
  • Draper ES, Rankin J, Tonks AM, et al. Recreational drug use: a major risk factor for gastroschisis?. Am J Epidemiol. 2008 Feb 15;167(4):485–491.
  • Forrester MB, Merz RD. Risk of selected birth defects with prenatal illicit drug use, Hawaii, 1986-2002. J Toxicol Environ Health. 2007 Jan;70(1):7–18.
  • Skarsgard ED, Meaney C, Bassil K, et al. Maternal risk factors for gastroschisis in Canada. Birth Defects Res A Clin Mol Teratol. 2015 Feb;103(2):111–118.
  • Torfs CP, Velie EM, Oechsli FW, et al. A population-based study of gastroschisis: demographic, pregnancy, and lifestyle risk factors. Teratology. 1994 Jul;50(1):44–53.
  • van Gelder MM, Reefhuis J, Caton AR, et al. Maternal periconceptional illicit drug use and the risk of congenital malformations. Epidemiology. 2009 Jan;20(1):60–66.
  • Werler MM, Sheehan JE, Mitchell AA. Association of vasoconstrictive exposures with risks of gastroschisis and small intestinal atresia. Epidemiology. 2003 May;14(3):349–354.
  • Volkow ND, Compton WM, Weiss SR. Adverse health effects of marijuana use. N Engl J Med. 2014 Aug 28;371(9):879.
  • Bindukumar B, Mahajan SD, Reynolds JL, et al. Genomic and proteomic analysis of the effects of cannabinoids on normal human astrocytes. Brain Res. 2008 Jan;29(1191):1–11.
  • Boa-AmponsemO, ZhangC, MukhopadhyayS, et al. Birth Defects Res. In: Ethanol and cannabinoids interact to alter behavior in a zebrafish fetal alcohol spectrum disorder model. Birth Defects Research. 2019 Jan 16.[Epub ahead of print].doi:10.1002/bdr2.1458.
  • Subbanna S, Nagre NN, Shivakumar M, et al. CB1R-Mediated Activation of Caspase-3 Causes Epigenetic and Neurobehavioral Abnormalities in Postnatal Ethanol-Exposed Mice. Front Mol Neurosci. 2018;11:45.
  • Nagre NN, Subbanna S, Shivakumar M, et al. CB1-receptor knockout neonatal mice are protected against ethanol-induced impairments of DNMT1, DNMT3A, and DNA methylation. J Neurochem. 2015 Feb;132(4):429–442.
  • Banik A, Kandilya D, Ramya S, et al. Maternal Factors that Induce Epigenetic Changes Contribute to Neurological Disorders in Offspring. Genes (Basel). 2017 May 24;8(6). doi:10.3390/genes8060150.
  • Chater-Diehl EJ, Laufer BI, Singh SM. Changes to histone modifications following prenatal alcohol exposure: an emerging picture. Alcohol. 2017 May;60:41–52.
  • Lunde ER, Washburn SE, Golding MC, et al. Alcohol-Induced Developmental Origins of Adult-Onset Diseases. Alcohol Clin Exp Res. 2016 Jul;40(7):1403–1414.
  • Veazey KJ, Wang H, Bedi YS, et al. Disconnect between alcohol-induced alterations in chromatin structure and gene transcription in a mouse embryonic stem cell model of exposure. Alcohol. 2017 May;60:121–133. (Fayetteville, NY.
  • Fauci AS, Braunwald E, Kapser DL, et al. editors. Harrison’s Principles of Internal Medicine, 17th Edition. 17th Edition. New York: McGraw Hill; 2008.
  • Smith AM, Fried PA, Hogan MJ, et al. Effects of prenatal marijuana on visuospatial working memory: an fMRI study in young adults. Neurotoxicol Teratol. 2006 Mar-Apr;28(2):286–295.
  • Smith AM, Longo CA, Fried PA, et al. Effects of marijuana on visuospatial working memory: an fMRI study in young adults. Psychopharmacology (Berl). 2010 Jun;210(3):429–438.
  • Smith AM, Mioduszewski O, Hatchard T, et al. Prenatal marijuana exposure impacts executive functioning into young adulthood: an fMRI study. Neurotoxicol Teratol. 2016;58:53–59.
  • Brents L. Correlates and consequences of Prenatal Cannabis Exposure (PCE): identifying and Characterizing Vulnerable Maternal Populations and Determining Outcomes in Exposed Offspring. In: Preedy VR, editor. Handbook of Cannabis and Related Pathologies: biology, Pharmacology, Diagnosis and Treatment. Vol. 1. London: Academic Press; 2017. p. 160–170.
  • National Birth Defects Prevention Network. National Birth Defects Prevention Network Houston, Texas, USA: National Birth Defects Prevention Network; 2018 [cited 2018 Jul 15]. Available from: https://www.nbdpn.org/ar.php
  • Nevison C, Blaxill M, Zahorodny W. California Autism Prevalence Trends from 1931 to 2014 and Comparison to National ASD Data from IDEA and ADDM. J Autism Dev Disord. 2018 Dec;48(12):4103–4117.
  • Public Health Agency of Canada, Health Canada. Congenital Anomalies in Canada, 2013. A Perinatal Health Surveillance Report. In: Public Health Agency of Canada, Health Canada. Ottawa: Health Canada; 2013. p. 1–119.
  • Statistics Canada. National Cannabis Survey, Second Quarter, 2018 Ottawa Canada: Statistics Canada; 2018 [cited 2019 Mar 17]. Available from: https://www.facebook.com/StatisticsCanada/posts/1636405843137586:0
  • Colorado: Department of Public Health and the Environment. Colorado Responds to Children with Special Needs - Birth Defect Data, Colorado. In: Environment CDoPHat. Denver Colorado, USA: Colorado: Department of Public Health and the Environment; 2018. http://www.chd.dphe.state.co.us/cohid/
  • Substance Abuse and Mental Health Administration, Department of Health and Human Services, United States Government. National Survey of Drug Use and Health 2018, NSDUH Bethesda, Maryland: Substance Abuse and Mental Health Administration, Department of Health and Human Services, United States Government,; 2018 [cited 2 June, 2018]. Available from: https://www.samhsa.gov/data/all-reports
  • Reece AS, Hulse GK. Effect of Cannabis Legalization on US Autism Incidence and Medium Term Projections. Clin Pediatr Open Access. 2019;4(2). In Press.
  • Reece AS, Hulse GK Epidemiological Associations of Various Substances and Multiple Cannabinoids with Autism in USA. Submitted to Pediatrics. 2019.
  • Willsher K Baby arm defects prompt nationwide investigation in France. Guardian. 2018. https://www.theguardian.com/world/2018/oct/31/baby-arm-defects-prompt-nationwide-investigation-france
  • Agence France-Presse in Paris. France to investigate cause of upper limb defects in babies. The Guardian. 2018 [cited 2018 Nov 3][https://www.theguardian.com/world/2018/oct/21/france-to-investigate-cause-of-upper-limb-defects-in-babies
  • Huang H, Liu S, Kornberg TB. Glutamate signaling at cytoneme synapses. Science. 2019 Mar 1;363(6430):948–955.
  • Baylin SB, Herman JG. DNA hypermethylation in tumorigenesis: epigenetics joins genetics. Trends Genet. 2000 Apr;16(4):168–174.
  • Chiba T, Marusawa H, Ushijima T. Inflammation-associated cancer development in digestive organs: mechanisms and roles for genetic and epigenetic modulation. Gastroenterology. 2012 Sep;143(3):550–563.
  • Issa JP, Ahuja N, Toyota M, et al. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res. 2001 May 1;61(9):3573–3577.
  • Vaz M, Hwang SY, Kagiampakis I, et al. Chronic Cigarette Smoke-Induced Epigenomic Changes Precede Sensitization of Bronchial Epithelial Cells to Single-Step Transformation by KRAS Mutations. Cancer Cell. 2017 Sep 11;32(3):360–376 e6.
  • O’Hagan HM, Wang W, Sen S, et al. Oxidative damage targets complexes containing DNA methyltransferases, SIRT1, and polycomb members to promoter CpG Islands. Cancer Cell. 2011 Nov 15;20(5):606–619.
  • Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer. 2004 Dec;4(12):988–993.
  • Niwa T, Ushijima T. Induction of epigenetic alterations by chronic inflammation and its significance on carcinogenesis. Adv Genet. 2010;71:41–56.
  • Maegawa S, Gough SM, Watanabe-Okochi N, et al. Age-related epigenetic drift in the pathogenesis of MDS and AML. Genome Res. 2014 Apr;24(4):580–591.
  • Reece AS, Norman A, Hulse GK. Cannabis Exposure as an Interactive Cardiovascular Risk Factor and Accelerant of Organismal Ageing – A Longitudinal Study. BMJ Open. 2016 Nov 7;6(11):e011891. doi:10.1136/bmjopen-2016-01189.
  • De Cecco M, Ito T, Petrashen AP, et al. L1 drives IFN in senescent cells and promotes age-associated inflammation. Nature. 2019 Feb;566(7742):73–78.
  • Andriani GA, Almeida VP, Faggioli F, et al. Whole Chromosome Instability induces senescence and promotes SASP. Sci Rep. 2016 Oct;12(6):35218.
  • Cannizzo ES, Clement CC, Sahu R, et al. Oxidative stress, inflamm-aging and immunosenescence. J Proteomics. 2011 Oct 19;74(11):2313–2323.
  • Salminen A, Huuskonen J, Ojala J, et al. Activation of innate immunity system during aging: NF-kB signaling is the molecular culprit of inflamm-aging. Ageing Res Rev. 2008 Apr;7(2):83–105.
  • Reece AS, Norman A, Hulse GK. Cannabis Exposure as an Interactive Cardiovascular Risk Factor and Accelerant of Organismal Ageing – A Longitudinal Study. BMJ - Open. 2016;6(11):e011891–e011900.
  • Zimmerman AM, Zimmerman S, Raj AY, et al. Effects of Cannabinoids on spermatogenesis in mice. In: Nahas GG, Sutin KM, Harvey DJeditors. Marihuana and medicine. Totowa, N.J, USA: Humana Press; 1999. p. 347–358.
  • Zimmerman AM, Raj AY. Influence of cannabinoids on somatic cells in vivo. Pharmacology. 1980;21(4):277–287.
  • Zimmerman S, Zimmerman AM. Genetic effects of marijuana. Int J Addict. 1990;25(1A):19–33.
  • Zimmerman AM, Bruce WR, Zimmerman S. Effects of cannabinoids on sperm morphology. Pharmacology. 1979;18(3):143–148.
  • Hembree WC 3rd, Nahas GG, Zeidenberg P, et al. Changes in human spermatozoa associated with high dose marihuana smoking. Adv Biosci. 1978 Jul 22-23;22-23:429–439.
  • Huang HFSNGG, Hembree WC. Effects of marijuana inhalation on spermatogenesis of the rat. In: Nahas GGSKM, Harvey DJ, Agurell S, editors. Marijuana and medicine. Totowa, New Jersey: Humana Press; 1999. p. 359–366.
  • Morishima A. Effects of cannabis and natural cannabinoids on chromosomes and ova. NIDA Res Monogr. 1984;44:25–45.
  • Mihalas BP, Redgrove KA, McLaughlin EA, et al. Molecular Mechanisms Responsible for Increased Vulnerability of the Ageing Oocyte to Oxidative Damage. Oxid Med Cell Longev. 2017;2017:4015874.
  • Di Nisio V, Rossi G, Palmerini MG, et al. Increased rounds of gonadotropin stimulation have side effects on mouse fallopian tubes and oocytes. Reproduction. 2018 Mar;155(3):245–250.
  • Hughes SE, Miller DE, Miller AL, et al. Female Meiosis: synapsis, Recombination, and Segregation in Drosophila melanogaster. Genetics. 2018 Mar;208(3):875–908.
  • Stefanis CN, Issidorides MR. Cellular Effects of Chronic Cannabis Use in Man. In: Nahas GG, editor. Marihuana: chemistry, Biochemistry and Cellular Effects. Vol. 1. New York: Springer; 1976. p. 533–550.
  • Reece AS, Hulse GK. Chromothripsis and epigenomics complete causality criteria for cannabis- and addiction-connected carcinogenicity, congenital toxicity and heritable genotoxicity. Mutat Res. 2016 Jul;789:15–25.
  • Piatti E, Rizzi R, Re F, et al. Genotoxicity of heroin and cannabinoids in humans. Pharmacol Res. 1989;Nov-Dec;21(Suppl 1):59–60.
  • Van Went GF. Mutagenicity testing of 3 hallucinogens: LSD, psilocybin and delta 9-THC, using the micronucleus test. Experientia. 1978 Mar 15;34(3):324–325.
  • Pellestor F. Chromoanagenesis: cataclysms behind complex chromosomal rearrangements. Mol Cytogenet. 2019;12:6.
  • Kloosterman WP, Guryev V, van Roosmalen M, et al. Chromothripsis as a mechanism driving complex de novo structural rearrangements in the germline. Hum Mol Genet. 2011 May 15;20(10):1916–1924.
  • Gluck S, Guey B, Gulen MF, et al. Innate immune sensing of cytosolic chromatin fragments through cGAS promotes senescence. Nat Cell Biol. 2017 Sep;19(9):1061–1070.
  • Mackenzie KJ, Carroll P, Martin CA, et al. cGAS surveillance of micronuclei links genome instability to innate immunity. Nature. 2017 Aug 24;548(7668):461–465.
  • Yang H, Wang H, Ren J, et al. cGAS is essential for cellular senescence. Proc Natl Acad Sci U S A. 2017 Jun 6;114(23):E4612–E4620.
  • Ablasser A, Chen ZJ. cGAS in action: expanding roles in immunity and inflammation. Science. 2019;363(6431):eaat8657.
  • Bakhoum SF, Ngo B, Laughney AM, et al. Chromosomal instability drives metastasis through a cytosolic DNA response. Nature. 2018 Jan 25;553(7689):467–472.
  • Van Gelder MMHJ, Donders ART, Devine O, et al. Using bayesian models to assess the effects of under-reporting of cannabis use on the association with birth defects, national birth defects prevention study, 1997-2005 [Article]. Paediatr Perinat Epidemiol. 2014;28(5):424–433.
  • Van Gelder MMHJ, Reefhuis J, Caton AR, et al. Maternal periconceptional illicit drug use and the risk of congenital malformations. Epidemiology. 2009 January;20(1):60–66.
  • Liu W, Komiya Y, Mezzacappa C, et al. MIM regulates vertebrate neural tube closure. Development. 2011 May;138(10):2035–2047.
  • Harper KL, Sosa MS, Entenberg D, et al. Mechanism of early dissemination and metastasis in Her2(+) mammary cancer. Nature. 2016 Dec 22;540(7634):588–592.
  • Janda CY, Dang LT, You C, et al. Surrogate Wnt agonists that phenocopy canonical Wnt and beta-catenin signalling. Nature. 2017 May 11;545(7653):234–237.
  • Tammela T, Sanchez-Rivera FJ, Cetinbas NM, et al. A Wnt-producing niche drives proliferative potential and progression in lung adenocarcinoma. Nature. 2017 May 18;545(7654):355–359.
  • Northcott PA, Buchhalter I, Morrissy AS, et al. The whole-genome landscape of medulloblastoma subtypes. Nature. 2017 Jul 19;547(7663):311–317.
  • Szenker-Ravi E, Altunoglu U, Leushacke M, et al. RSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently of LGR4/5/6. Nature. 2018 May;557(7706):564–569.
  • Liyanage VRB, Olson CO, Zachariah RM, et al. DNA Methylation Contributes to the Differential Expression Levels of Mecp2 in Male Mice Neurons and Astrocytes. Int J Mol Sci. 2019 Apr 14;20(8). pii: E1845. doi: 10.3390/ijms20081845.
  • Kuehner JN, Bruggeman EC, Wen Z, et al. Epigenetic Regulations in Neuropsychiatric Disorders. Front Genet. 2019;10:268.
  • Garg P, Sharp AJ. Screening for rare epigenetic variations in autism and schizophrenia. Hum Mutat. 2019 Mar 21. doi:10.1002/humu.23740. [Epub ahead of print].
  • Bend EG, Aref-Eshghi E, Everman DB, et al. Gene domain-specific DNA methylation episignatures highlight distinct molecular entities of ADNP syndrome. Clin Epigenetics. 2019 Apr 27;11(1):64.
  • Alex AM, Saradalekshmi KR, Shilen N, et al. IUBMB Life. In: Genetic association of DNMT variants can play a critical role in defining the methylation patterns in autism. IUBMB Life. 2019 Jul;71(7):901–907. doi:10.1002/iub.2021. Epub 2019 Feb 20.
  • Krol KM, Puglia MH, Morris JP, et al. Epigenetic modification of the oxytocin receptor gene is associated with emotion processing in the infant brain. Dev Cogn Neurosci. 2019;37:100648.
  • Russo C, Ferk F, Misik M, et al. Low doses of widely consumed cannabinoids (cannabidiol and cannabidivarin) cause DNA damage and chromosomal aberrations in human-derived cells. Arch Toxicol. 2019 Jan;93(1):179–188. Epub 2018 Oct 19.doi: 10.1007/s00204-018-2322-9.
  • Zimmerman AM, Zimmerman S, Raj AY. Effects of Cannabinoids on Spermatogensis in Mice. In: Nahas GG, Sutin KM, Harvey DJ, et al., editors. Marijuana and Medicine. Vol. 1. Totowa, New York: Humana Press; 1999. p. 347–358.
  • Chiu P, Karler R, Craven C, et al. The influence of delta9-tetrahydrocannabinol, cannabinol and cannabidiol on tissue oxygen consumption. Res Commun Chem Pathol Pharmacol. 1975 Oct;12(2):267–286.
  • Fisar Z, Singh N, Hroudova J. Cannabinoid-induced changes in respiration of brain mitochondria. Toxicol Lett. 2014 Nov 18;231(1):62–71.
  • Hayakawa K, Mishima K, Hazekawa M, et al. Cannabidiol potentiates pharmacological effects of Delta(9)-tetrahydrocannabinol via CB(1) receptor-dependent mechanism. Brain Res. 2008 Jan 10;1188:157–164.
  • Mato S, Victoria Sanchez-Gomez M, Matute C. Cannabidiol induces intracellular calcium elevation and cytotoxicity in oligodendrocytes. Glia. 2010 Nov 1;58(14):1739–1747.
  • Silvestri C, Di Marzo V. The endocannabinoid system in energy homeostasis and the etiopathology of metabolic disorders. Cell Metab. 2013 Apr 2;17(4):475–490.
  • Rimmerman N, Ben-Hail D, Porat Z, et al. Direct modulation of the outer mitochondrial membrane channel, voltage-dependent anion channel 1 (VDAC1) by cannabidiol: a novel mechanism for cannabinoid-induced cell death. Cell Death Dis. 2013 Dec 5;4:e949.
  • Ryan D, Drysdale AJ, Lafourcade C, et al. Cannabidiol targets mitochondria to regulate intracellular Ca2+ levels. J Neurosci. 2009 Feb 18;29(7):2053–2063.
  • Singh N, Hroudova J, Fisar Z. Cannabinoid-Induced Changes in the Activity of Electron Transport Chain Complexes of Brain Mitochondria. J Mol Neurosci. 2015 Aug;56(4):926–931.
  • Alhamoruni A, Lee AC, Wright KL, et al. Pharmacological effects of cannabinoids on the Caco-2 cell culture model of intestinal permeability. J Pharmacol Exp Ther. 2010 Oct;335(1):92–102.
  • Da Silva JA, Biagioni AF, Almada RC, et al. Dissociation between the panicolytic effect of cannabidiol microinjected into the substantia nigra, pars reticulata, and fear-induced antinociception elicited by bicuculline administration in deep layers of the superior colliculus: the role of CB1-cannabinoid receptor in the ventral mesencephalon. Eur J Pharmacol. 2015 Jul 5;758:153–163.
  • Hwang YS, Kim YJ, Kim MO, et al. Cannabidiol upregulates melanogenesis through CB1 dependent pathway by activating p38 MAPK and p42/44 MAPK. Chem Biol Interact. 2017 Aug 1;273:107–114.
  • Laprairie RB, Bagher AM, Kelly ME, et al. Cannabidiol is a negative allosteric modulator of the cannabinoid CB1 receptor. Br J Pharmacol. 2015 Oct;172(20):4790–4805.
  • Sartim AG, Guimaraes FS, Joca SR. Antidepressant-like effect of cannabidiol injection into the ventral medial prefrontal cortex-Possible involvement of 5-HT1A and CB1 receptors. Behav Brain Res. 2016 Apr 15;303:218–227.
  • Stanley CP, Hind WH, Tufarelli C, et al. Cannabidiol causes endothelium-dependent vasorelaxation of human mesenteric arteries via CB1 activation. Cardiovasc Res. 2015 Sep 1;107(4):568–578.
  • Stern CAJ, Da Silva TR, Raymundi AM, et al. Cannabidiol disrupts the consolidation of specific and generalized fear memories via dorsal hippocampus CB1 and CB2 receptors. Neuropharmacology. 2017;125:220–230.
  • Pucci M, Rapino C, Di Francesco A, et al. Epigenetic control of skin differentiation genes by phytocannabinoids. Br J Pharmacol. 2013 Oct;170(3):581–591.
  • De Filippis D, Esposito G, Cirillo C, et al. Cannabidiol reduces intestinal inflammation through the control of neuroimmune axis. PLoS One. 2011;6(12):e28159.
  • Esposito G, Scuderi C, Valenza M, et al. Cannabidiol reduces Abeta-induced neuroinflammation and promotes hippocampal neurogenesis through PPARgamma involvement. PLoS One. 2011;6(12):e28668.
  • Hegde VL, Singh UP, Nagarkatti PS, et al. Critical Role of Mast Cells and Peroxisome Proliferator-Activated Receptor gamma in the Induction of Myeloid-Derived Suppressor Cells by Marijuana Cannabidiol In Vivo. J Immunol. 2015 Jun 1;194(11):5211–5222.
  • Hind WH, England TJ, O’Sullivan SE. Cannabidiol protects an in vitro model of the blood-brain barrier from oxygen-glucose deprivation via PPARgamma and 5-HT1A receptors. Br J Pharmacol. 2016 Mar;173(5):815–825.
  • O’Sullivan SE, Kendall DA. Cannabinoid activation of peroxisome proliferator-activated receptors: potential for modulation of inflammatory disease. Immunobiology. 2010 Aug;215(8):611–616.
  • O’Sullivan SE, Sun Y, Bennett AJ, et al. Time-dependent vascular actions of cannabidiol in the rat aorta. Eur J Pharmacol. 2009 Jun 10;612(1–3):61–68.
  • Ramer R, Heinemann K, Merkord J, et al. COX-2 and PPAR-gamma confer cannabidiol-induced apoptosis of human lung cancer cells. Mol Cancer Ther. 2013 Jan;12(1):69–82.
  • Scuderi C, Steardo L, Esposito G. Cannabidiol promotes amyloid precursor protein ubiquitination and reduction of beta amyloid expression in SHSY5YAPP+ cells through PPARgamma involvement. Phytother Res. 2014 Jul;28(7):1007–1013.
  • Tyagi S, Gupta P, Saini AS, et al. The peroxisome proliferator-activated receptor: A family of nuclear receptors role in various diseases. J Adv Pharm Technol Res. 2011 Oct;2(4):236–240.
  • Cutando L, Maldonado R, Ozaita A. Microglial Activation and Cannabis Exposure. In: Preedy V. editor. Handbook of Cannabis and Related Pathologies: Biology, Pharmacology, Diagnosis and Treatment. New York: Academic Press; 2017:401–12.
  • Leos-Toro C, Reid JL, Madill CL, et al. Cannabis in Canada - Tobacco Use in Canada: patterns and Trends, 2017 Edition, Special Supplement. In: PROPEL, Centre for Population Health Impact, Waterloo University, editors. Cannabis in Canada: patterns and Trends, 2017. Waterloo, Ontario: University of Waterloo; 2017. p. 1–23.
  • Public Health Agency of Canada. Congenital Anomalies in Canada, 2013. A Perinatal Health Surveillance Report In: public Health Agency of Canada HC, editor. Ottawa: Health Canada; 2013. p. 1–115.
  • Arbour L, Gilpin C, Millor-Roy V, et al. Heart defects and other malformations in the Inuit in Canada: a baseline study. Int J Circumpolar Health. 2004 Sep;63(3):251–266.
  • Pacher P, Steffens S, Hasko G, et al. Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly. Nat Rev Cardiol. 2018 Mar;15(3):151–166.
  • Frampton G, Coufal M, Li H, et al. Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling. Exp Cell Res. 2010 May 15;316(9):1465–1478.
  • Newton CA, Chou PJ, Perkins I, et al. CB(1) and CB(2) cannabinoid receptors mediate different aspects of delta-9-tetrahydrocannabinol (THC)-induced T helper cell shift following immune activation by Legionella pneumophila infection. J Neuroimmune Pharmacol. 2009 Mar;4(1):92–102.
  • Tanveer R, Gowran A, Noonan J, et al. The endocannabinoid, anandamide, augments Notch-1 signaling in cultured cortical neurons exposed to amyloid-beta and in the cortex of aged rats. J Biol Chem. 2012 Oct 5;287(41):34709–34721.
  • BM C. Human Embryology and Developmental Biology. Vol. 1. Philadelphia: Elsevier; 2014.
  • Basu M, Zhu JY, LaHaye S, et al. Epigenetic mechanisms underlying maternal diabetes-associated risk of congenital heart disease. In: J. Clin. Iinvest. Insight. 2017 Oct 19;2(20). pii: 95085. doi:10.1172/jci.insight.95085.
  • Chatterjee R, Law S. Epigenetic and microenvironmental alterations in bone marrow associated with ROS in experimental aplastic anemia. Eur J Cell Biol. 2018 Jan;97(1):32–43.
  • Kwon H, Song K, Han C, et al. Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: impact on Regulation of Notch Pathway. Am J Pathol. 2017 Oct;187(10):2288–2299.
  • Jin L, Vu T, Yuan G, et al. STRAP Promotes Stemness of Human Colorectal Cancer via Epigenetic Regulation of the NOTCH Pathway. Cancer Res. 2017 Oct 15;77(20):5464–5478.
  • Katoh M. Canonical and non-canonical WNT signaling in cancer stem cells and their niches: cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review). Int J Oncol. 2017 Nov;51(5):1357–1369.
  • Kuang SQ, Fang Z, Zweidler-McKay PA, et al. Epigenetic inactivation of Notch-Hes pathway in human B-cell acute lymphoblastic leukemia. PLoS One. 2013;8(4):e61807.
  • Lian H, Jia X, Shi N, et al. Notch signaling promotes serrated neoplasia pathway in colorectal cancer through epigenetic modification of EPHB2 and EPHB4. Cancer Manag Res. 2018;10:6129–6141.
  • Geber WF, Schramm LC. Teratogenicity of marihuana extract as influenced by plant origin and seasonal variation. Arch Int Pharmacodyn Ther. 1969 Jan;177(1):224–230.
  • Graham JDP. Cannabis and Health. In: Graham JDP, editor. Cannabis and Health. Vol. 1. 1 ed ed. London, New York, San Francisco: Academic Press; 1976. p. 271–320.